by Simona Gilman | Jan 5, 2020 | Featured Posts, Press Releases
Merck GHI joins leading biopharma companies Amgen, BMS, Zambon Pharmaceuticals, and leading health plans Cigna, Cambia Health Solutions, Echo Health Ventures, Horizon Blue Cross of NJ, and Heritage Provider Network, as an investor in GNS Healthcare. CAMBRIDGE, Mass. –...
by wpengine | Jul 9, 2019 | Featured Posts, Press Releases
Cigna Ventures taps GNS’ technology and solutions to further advance whole person health for Cigna’s customers and clients Additional partners participating in recent funding round include Amgen Ventures, Celgene Corporation, Echo Health Ventures and Alexandria...
by wpengine | Jul 2, 2019 | Press Releases
AI-driven in silico patients used to identify heterogeneous landscape of clinical predictors of overall survival in populations of patients with metastatic colorectal cancer. CAMBRIDGE, Mass.– [July 2, 2019] – GNS Healthcare (GNS), a leading precision medicine...
by wpengine | Jun 3, 2019 | Press Releases
23rd FDA Commissioner to share his thoughts on the convergence of data and AI in the development and use of new medicines along with industry luminaries from biopharma, payers, and patient foundations CAMBRIDGE, Mass., June 3, 2019 /PRNewswire/ — GNS Healthcare...
by wpengine | May 29, 2019 | Press Releases
Innovative use of causal artificial intelligence to reveal the practices of medicine that drive improved health outcomes at lower costs MILWAUKEE and CAMBRIDGE, Mass., May 29, 2019 — The Business Health Care Group (BHCG), a coalition of employers located...
by wpengine | Oct 22, 2018 | Press Releases
Study identifies clinical and molecular drivers of survival at baseline to allow better risk stratification at initiation of treatment CAMBRIDGE, Mass.– [October 22, 2018] – GNS Healthcare (GNS), a leading precision medicine company, presented results in metastatic...
